Treatment of Shiga toxin–producing <i>E. coli</i> infection by CRISPR-Cas–targeted cleavage of the Shiga toxin gene in animal models

Matthieu Galtier(Eligo Bioscience (France)), Jesús Fernández-Rodríguez(Eligo Bioscience (France)), Andreas K. Brödel(Eligo Bioscience (France)), Marie Rouquette(Eligo Bioscience (France)), Olivier Kerbarh(Eligo Bioscience (France)), Aymeric Leveau(John Innes Centre), Giuseppina Salzano(Eligo Bioscience (France)), Daniel J. Garry(University of Minnesota), Aurélie Grienenberger(Eligo Bioscience (France)), Dalila Spadoni(Eligo Bioscience (France)), Gautier Prevot(Eligo Bioscience (France)), Edith M. Hessel(Eligo Bioscience (France)), Rémi Terrasse(Eligo Bioscience (France)), Xavier Duportet(Eligo Bioscience (France)), Jan Havránek(Eligo Bioscience (France)), Simone Pignotti(Eligo Bioscience (France)), Chloé Poquet(Eligo Bioscience (France)), Loïc H. Charpenay(Eligo Bioscience (France)), Benjamin Buhot(Eligo Bioscience (France)), Igor Stzepourginski(Eligo Bioscience (France)), Antoine Decrulle(Eligo Bioscience (France)), David Bikard(Institut Pasteur), Antonina Krawczyk(Eligo Bioscience (France)), Erica Lieberman(Eligo Bioscience (France)), Pablo Cárdenas Ramírez(Eligo Bioscience (France)), Camila Bramorski(Eligo Bioscience (France)), Fabien J. Fuche(Eligo Bioscience (France)), Kristin Muench(Eligo Bioscience (France)), Marion Arraou(Eligo Bioscience (France))
Science Translational Medicine
May 27, 2026
Cited by 0


Related Papers